Highest-materiality recent filing
McKesson Q1 adjusted EPS $9.93 (+20% YoY); raises FY2027 guidance to $44.20-$45.00
Revenue $105.4B (+8% YoY); GAAP EPS $5.15 (down $1.10); adjusted EPS $9.93 (+20%).
McKesson subsidiary adds $2.25B senior secured term loan facility due 2032
Amendment to April 1, 2026 Credit Agreement creates $2.25B Term B Loan Facility maturing 2032.
McKesson Q4 adj EPS $11.69 (+16% YoY); FY2027 guidance $43.80-$44.60
Q4 revenue $96.3B (+6%), full-year $403.4B (+12%); GAAP EPS $13.71, adjusted EPS $39.11 (+18% FY).
McKesson Q3 revenue $106.2B +11%, adj EPS $9.34 +16%, raises FY guidance
GAAP EPS $9.59 vs $6.95 YoY; adjusted EPS $9.34 vs $8.03, up 16%.
McKesson Q2 adjusted EPS $9.86, +39% YoY; revenue record $103.2B; raises FY26 guidance
Quarterly revenue $103.2B (+10% YoY); GAAP EPS $8.92 vs $1.87; adjusted EPS $9.86 vs $7.07 (+39%).
Fiscal 2026 Adjusted EPS guidance raised and narrowed to $38.05-$38.55 from $37.10-$37.90.
Consolidated revenue $97.8B, up 23% YoY; GAAP diluted EPS $6.25 (down $0.75); Adjusted EPS $8.26 (up 5%).
McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization
Issued $650M 4.650% notes due 2030, $650M 4.950% notes due 2032, $700M 5.250% notes due 2035.
Q4 consolidated revenues $90.8B (+19% YoY); GAAP diluted EPS $10.01; adjusted diluted EPS $10.12 (+64%).
McKesson Q3 FY25 revenue $95.3B (+18%); raises adjusted EPS guidance to $32.55-$32.95
Q3 FY25 revenue $95.3B (+18% YoY); GAAP EPS $6.95 (+57%); adjusted EPS $8.03 (+4%).
GAAP diluted EPS $6.95 vs $4.42 prior year; adjusted EPS $8.03 vs $7.74 (+4%).
McKesson Q2 FY2025 revenue $93.7B (+21%), adj. EPS $7.07 (+13%), raises FY25 adj. EPS guidance
Revenue $93.7B, +21% YoY; GAAP diluted EPS $1.87 (down 62% vs $4.92); adjusted EPS $7.07 (+13%).
McKesson issues $500M 4.250% notes due 2029 to redeem higher-rate 2026 notes
Issued $500M aggregate principal of 4.250% Notes due 2029 at 99.946% of par.
McKesson signs deal to buy 70% of Core Ventures (FCS) for ~$2.49B cash
Purchase price approx. $2.49B in cash for ~70% controlling equity interest in Core Ventures (FCS's admin services org).
McKesson Q1 adjusted EPS $7.88 (+8% YoY); raises FY2025 guidance, boosts dividend 15%
Revenues $79.3B (+6% YoY); net income $915M (-4%); GAAP EPS $7.00 flat.
McKesson Q4 revenue +11% but adjusted EPS -14%; FY2025 guidance 14-17% growth
Q4 revenue $76.4B (+11% YoY); full-year revenue $309B (+12% YoY).
McKesson FQ3 revenue $80.9B (+15% YoY), adjusted EPS $7.74 (+12%), raises FY guidance
Revenue $80.9B up 15% YoY; GAAP EPS from continuing ops $4.42 vs $7.65 (down 42%).
McKesson acquires healthcare data platform Compile; adds Kevin Ozan to board
Kevin Ozan elected to McKesson board, effective Jan 8, 2024; board expands to 12 members.
McKesson Q2 revenue $77.2B (+10%), adj EPS $6.23; raises FY24 guidance; CLO succession
Total revenues $77.2B, up 10% YoY; income from continuing ops $664M (-29%).
McKesson Q1 FY2024 revenues $74.5B (+11%); adj EPS $7.27 (+25%); raises FY guidance
Revenues $74.5B, up 11% YoY; income from cont ops $958M (+25%).
McKesson commences tender offer for any and all $918M of 3.796% Notes due 2024
Tender offer for any and all $918,070,000 of 3.796% Notes due 2024; expires June 13, 2023.
McKesson Q4 adjusted EPS $7.19 (+23% YoY); FY2024 guidance $26.10-$26.90
Q4 revenues $68.9B (+4% YoY); full-year revenues $276.7B (+5%).
McKesson Q3 FY23: EPS $7.65, adj. EPS $6.90; raises full-year guidance to $25.75-$26.15
Total revenues $70.5B (+3%); GAAP diluted EPS $7.65 vs. ($0.04) YoY.
McKesson Q2 revenue $70.2B (+5%), EPS $6.46 vs $1.71; raises FY23 adj. EPS guidance to $24.45-24.95
Total revenues of $70.2B increased 5% YoY; income from continuing operations $932M vs $267M.
McKesson Q1 adj EPS $5.83, revenue $67.2B; raises FY2023 outlook to $23.95-$24.65
Adjusted EPS $5.83 vs $5.56 (+5%); GAAP EPS $5.25 vs $3.09 (+70%).
McKesson Q4 revenue $66.1B (+12%), adj EPS $5.83 (+15%); FY2023 adj EPS guide $22.90-$23.60
Q4 revenues $66.1B (+12% YoY); diluted EPS from cont ops $2.48 (vs $4.15 prior year).
Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.
On May 31, 2024, the Board of Directors (“Board”) of McKesson Corporation (“Corporation”) elected Deborah Dunsire, M.D. as a director of the Corporation and appointed her to the Board’s Compensation and Talent Committee and Finance Committee, effective June 3, 2024.
Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.
On January 8, 2024, the Board of Directors (“Board”) of McKesson Corporation (“Corporation”) elected Kevin Ozan as a director of the Corporation and appointed him to the Board’s Audit Committee and Finance Committee, effective January 8, 2024.
On October 27, 2023, Lori A. Schechter, the Company’s Chief Legal Officer, gave notice of her intention to retire from that role as further described in Exhibit 99.1 under the heading Executive Leadership Transition.
Nancy Avila, Executive Vice President, Chief Information Officer and Chief Technology Officer stepped down from her role and as an executive officer of the Company effective October 2, 2023.
On September 7, 2022, Tracy L. Faber, Executive Vice President and Chief Human Resources Officer, who is a named executive officer of McKesson Corporation (“Company”), gave the Company notice of her decision to retire from the Company effective on December 1, 2022.
On March 31, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected W. Roy Dunbar as a director of the Corporation, and appointed him to the Audit Committee and Governance Committee, effective on April 1, 2022.
On February 21, 2022, Napoleon B. Rutledge, Jr., 49, was appointed as Senior Vice President, Controller and Chief Accounting Officer of McKesson Corporation
In connection with Mr. Rutledge's appointment, Kevin W. Emerson will be leaving his interim positions as the Company's Controller and Chief Accounting Officer.
On January 13, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected James H. Hinton and Kathleen Wilson-Thompson as directors of the Corporation effective on January 13, 2022.
On January 13, 2022, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected James H. Hinton and Kathleen Wilson-Thompson as directors of the Corporation effective on January 13, 2022.
Max materiality 0.90 · Median 0.60 · Most common event earnings